H Muramatsu Selected Research

H Muramatsu Research Topics

Disease

6	Neoplasms (Cancer) 07/2012 - 02/2000
3	Infarction (Infarctions) 05/2001 - 02/2000
3	Carcinoma (Carcinomatosis) 01/2001 - 04/2000
2	Aplastic Anemia (Anemia, Hypoplastic) 12/2017 - 10/2015
2	Hepatitis 04/2012 - 12/2001
2	Head and Neck Neoplasms (Head and Neck Cancer) 11/2002 - 01/2001
2	Ischemia 08/2001 - 05/2001
2	Neoplasm Metastasis (Metastasis) 08/2001 - 01/2001
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2001 - 01/2001
1	Cross Infection (Nosocomial Infection) 03/2022
1	Malnutrition (Nutritional Deficiencies) 12/2017
1	Aspiration Pneumonia 01/2016
1	Hiatal Hernia 01/2016
1	Gastroesophageal Reflux (GERD) 01/2016
1	Hypersensitivity (Allergy) 07/2012
1	Constipation 04/2007
1	Diarrhea 02/2007
1	Stomach Neoplasms (Stomach Cancer) 03/2003
1	Mucositis 11/2002
1	Septic Shock (Toxic Shock Syndrome) 12/2001
1	Alopecia (Baldness) 12/2001
1	Asthma (Bronchial Asthma) 06/2001
1	Brain Ischemia (Cerebral Ischemia) 05/2001
1	Cerebral Infarction 05/2001
1	Alzheimer Disease (Alzheimer's Disease) 01/2001
1	Amyloid Plaque 01/2001
1	Hyperthermia 01/2001
1	Squamous Cell Carcinoma of Head and Neck 01/2001
1	Infections 09/2000
1	Inflammation (Inflammations) 09/2000
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2000
1	Keloid 04/2000
1	Cicatrix (Scar) 04/2000
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2000
1	Hodgkin Disease (Hodgkin's Disease) 04/2000
1	Lymphoma (Lymphomas) 04/2000
1	Neointima 02/2000

Drug/Important Bio-Agent (IBA)

3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2000 - 02/2000
3	MidkineIBA 09/2000 - 02/2000
2	mitemcinalIBA 04/2007 - 02/2007
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 12/2001 - 04/2000
2	Eosine Yellowish-(YS) (Eosin)IBA 05/2001 - 01/2001
2	Glucose (Dextrose)FDA LinkGeneric 05/2001 - 01/2001
2	Heparin (Liquaemin)FDA LinkGeneric 09/2000 - 02/2000
2	Proteins (Proteins, Gene)FDA Link 04/2000 - 02/2000
1	VaccinesIBA 03/2022
1	Rotavirus VaccinesIBA 03/2022
1	NitrogenIBA 12/2017
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2017
1	Contrast MediaIBA 01/2016
1	UbiquitinIBA 07/2012
1	src-Family KinasesIBA 07/2012
1	Ligases (Synthetase)IBA 07/2012
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2012
1	tyrosine receptor (receptor, tyrosine)IBA 07/2012
1	Phosphotransferases (Kinase)IBA 07/2012
1	Rituximab (Mabthera)FDA Link 04/2012
1	Morphine (MS Contin)FDA LinkGeneric 04/2007
1	Sennosides (Senokot)IBA 04/2007
1	Docetaxel (Taxotere)FDA Link 11/2002
1	Carboplatin (JM8)FDA LinkGeneric 11/2002
1	Caspase 3 (Caspase-3)IBA 12/2001
1	Syndecan-4IBA 12/2001
1	2,2'-methylenebis(1,3-cyclohexanedione)IBA 12/2001
1	Theophylline (Theon)FDA LinkGeneric 08/2001
1	1,3-dipropyl-8-cyclopentylxanthineIBA 08/2001
1	Thromboxane A2 (A2, Thromboxane)IBA 06/2001
1	11-dehydro-thromboxane B2IBA 06/2001
1	seratrodastIBA 06/2001
1	JTP 2942IBA 05/2001
1	Hematoxylin (Haematoxylon)IBA 05/2001
1	Thyrotropin-Releasing Hormone (Protirelin)FDA Link 05/2001
1	alpha-SynucleinIBA 01/2001
1	Superoxides (Superoxide)IBA 01/2001
1	Superoxide Dismutase-1IBA 01/2001
1	C-Reactive ProteinIBA 09/2000
1	FR 901469IBA 09/2000
1	nimesulide (Aulin)IBA 05/2000
1	Antineoplastic Agents (Antineoplastics)IBA 05/2000
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2000
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 05/2000
1	A-factor (Streptomyces)IBA 04/2000
1	Conditioned Culture MediaIBA 04/2000
1	CollagenIBA 04/2000
1	Coloring Agents (Dyes)IBA 02/2000
1	salicylhydroxamic acid (SHAM)IBA 02/2000
1	FR 182877IBA 02/2000

Therapy/Procedure

3	Radiotherapy 11/2002 - 01/2001
1	Enteral Nutrition (Feeding, Tube) 12/2017
1	Transplantation 12/2017
1	Gastrostomy 01/2016
1	Hematopoietic Stem Cell Transplantation 10/2015
1	Cell Transplantation 10/2015
1	Oral Administration 02/2007
1	Argon Plasma Coagulation 03/2003
1	Drug Therapy (Chemotherapy) 12/2001
1	Chemoradiotherapy 01/2001
1	Brachytherapy 01/2001
1	Subcutaneous Injections 09/2000